|
Volumn 18, Issue 2, 2014, Pages 249-250
|
Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ISONIAZID;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR INHIBITOR;
ADULT;
BACTERIUM DETECTION;
CASE REPORT;
COUGHING;
CROHN DISEASE;
FEVER;
HUMAN;
HUMAN CELL;
LETTER;
LUNG TUBERCULOSIS;
MALE;
MYCOBACTERIUM TUBERCULOSIS;
PLEURA EFFUSION;
PLEURA FLUID;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RECURRENT DISEASE;
REINFECTION;
THORAX RADIOGRAPHY;
YOUNG ADULT;
BACTERIUM CULTURE;
DISEASE ASSOCIATION;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
PRACTICE GUIDELINE;
TREATMENT DURATION;
TUBERCULOSIS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTITUBERCULAR AGENTS;
CROHN DISEASE;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LATENT TUBERCULOSIS;
MALE;
MYCOBACTERIUM TUBERCULOSIS;
OPPORTUNISTIC INFECTIONS;
RECURRENCE;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
TUBERCULOSIS, PULMONARY;
TUMOR NECROSIS FACTOR-ALPHA;
YOUNG ADULT;
|
EID: 84987784961
PISSN: 10273719
EISSN: None
Source Type: Journal
DOI: 10.5588/ijtld.13.0751 Document Type: Letter |
Times cited : (7)
|
References (4)
|